ANI Pharmaceuticals, Inc. (ANI) is an integrated specialty pharmaceutical company engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company's focused areas of product development include narcotics, oncolytics (anti-cancers), hormones and steroids, and complex formulations involving release and combination products. The Company has two pharmaceutical manufacturing facilities located in Baudette, Minnesota that are capable of producing oral solid dose products, as well as liquids and topicals, narcotics, and potent products. The Company's branded products consist of Cortenema, Lithobid, Reglan and Vancocin. Its generic products include Esterified Estrogen with Methyltestosterone, Fluvoxamine Maleate, Hydrocortisone Enema, Methazolamide, Metoclopramide and Opium Tincture. The Company's markets include hormone and steroidal drugs, oncolytics, and narcotics and complex formulations, including extended release and combination products.